靶标-话题@MedSci

#靶标#

218篇内容 | 4421人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1352696, encodeId=b483135269678, content=<a href='/topic/show?id=827d9996311' target=_blank style='color:#2F92EE;'>#靶标#</a>, objectTitle=Breast Cancer Res：蛋白Perp与细胞桥粒或成抑制乳腺癌新靶标, objectType=article, longId=5778, objectId=dfbc5e78c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dfbc5e78c2, replyNumber=0, likeNumber=87, createdTime=2012-04-27, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dfbc5e78c2, moduleTitle=Breast Cancer Res：蛋白Perp与细胞桥粒或成抑制乳腺癌新靶标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dfbc5e78c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1352695, encodeId=5c63135269577, content=<a href='/topic/show?id=827d9996311' target=_blank style='color:#2F92EE;'>#靶标#</a>, objectTitle=ImmunoCellular公司获卵巢癌新靶标EphA2使用许可, objectType=article, longId=5759, objectId=98d85e593a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=98d85e593a, replyNumber=0, likeNumber=72, createdTime=2012-04-27, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=98d85e593a, moduleTitle=ImmunoCellular公司获卵巢癌新靶标EphA2使用许可, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=98d85e593a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1352694, encodeId=82af135269436, content=<a href='/topic/show?id=827d9996311' target=_blank style='color:#2F92EE;'>#靶标#</a>, objectTitle=Nature：FLT3突变成急性髓细胞白血病治疗靶标, objectType=article, longId=5437, objectId=5586543e8f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5586543e8f, replyNumber=0, likeNumber=79, createdTime=2012-04-19, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5586543e8f, moduleTitle=Nature：FLT3突变成急性髓细胞白血病治疗靶标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5586543e8f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1352693, encodeId=638d13526934c, content=<a href='/topic/show?id=827d9996311' target=_blank style='color:#2F92EE;'>#靶标#</a>, objectTitle=EGFR可以作为NSCLC治疗靶标, objectType=article, longId=5170, objectId=a49351e034, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a49351e034, replyNumber=0, likeNumber=107, createdTime=2012-04-15, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a49351e034, moduleTitle=EGFR可以作为NSCLC治疗靶标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a49351e034)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1352692, encodeId=e03c135269220, content=<a href='/topic/show?id=827d9996311' target=_blank style='color:#2F92EE;'>#靶标#</a>, objectTitle=Cancer Cell：鉴定出混合性白血病的新药物靶标, objectType=article, longId=4852, objectId=714948524e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=714948524e, replyNumber=0, likeNumber=69, createdTime=2012-04-12, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=714948524e, moduleTitle=Cancer Cell：鉴定出混合性白血病的新药物靶标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=714948524e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1352691, encodeId=71da13526917c, content=<a href='/topic/show?id=827d9996311' target=_blank style='color:#2F92EE;'>#靶标#</a>, objectTitle=Nat.Med：HIPK2激酶——肾脏疾病药物新靶标, objectType=article, longId=4706, objectId=18ce4e0651, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=18ce4e0651, replyNumber=0, likeNumber=69, createdTime=2012-04-12, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=18ce4e0651, moduleTitle=Nat.Med：HIPK2激酶——肾脏疾病药物新靶标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=18ce4e0651)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1352690, encodeId=34481352690bf, content=<a href='/topic/show?id=827d9996311' target=_blank style='color:#2F92EE;'>#靶标#</a>, objectTitle=Nat.Med：HIPK2激酶——肾脏疾病药物新靶标, objectType=article, longId=4324, objectId=f8f943248a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f8f943248a, replyNumber=0, likeNumber=76, createdTime=2012-03-17, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f8f943248a, moduleTitle=Nat.Med：HIPK2激酶——肾脏疾病药物新靶标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f8f943248a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1352689, encodeId=31ef13526890c, content=<a href='/topic/show?id=827d9996311' target=_blank style='color:#2F92EE;'>#靶标#</a>, objectTitle=Cell：miR-124可能成为肝癌治疗新靶标, objectType=article, longId=4290, objectId=3bc84290a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3bc84290a6, replyNumber=0, likeNumber=123, createdTime=2012-03-12, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3bc84290a6, moduleTitle=Cell：miR-124可能成为肝癌治疗新靶标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3bc84290a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1352688, encodeId=0d4f135268809, content=<a href='/topic/show?id=827d9996311' target=_blank style='color:#2F92EE;'>#靶标#</a>, objectTitle=脂肪酸合成酶或成糖尿病治疗新靶标, objectType=article, longId=4119, objectId=ff854119fb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ff854119fb, replyNumber=0, likeNumber=74, createdTime=2012-02-26, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ff854119fb, moduleTitle=脂肪酸合成酶或成糖尿病治疗新靶标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ff854119fb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1352687, encodeId=3347135268e03, content=<a href='/topic/show?id=827d9996311' target=_blank style='color:#2F92EE;'>#靶标#</a>, objectTitle=Nat Med：去泛素酶USP15是潜在抗癌治疗靶标, objectType=article, longId=4107, objectId=7a1c410ef6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7a1c410ef6, replyNumber=0, likeNumber=71, createdTime=2012-02-26, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7a1c410ef6, moduleTitle=Nat Med：去泛素酶USP15是潜在抗癌治疗靶标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7a1c410ef6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1352686, encodeId=ace91352686ef, content=<a href='/topic/show?id=827d9996311' target=_blank style='color:#2F92EE;'>#靶标#</a>, objectTitle=Ann Neurol:大脑中的12/15-lipoxygenase可能是控制阿尔茨海默症的关键靶标, objectType=article, longId=3796, objectId=7cf93e9654, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7cf93e9654, replyNumber=0, likeNumber=80, createdTime=2012-01-31, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7cf93e9654, moduleTitle=Ann Neurol:大脑中的12/15-lipoxygenase可能是控制阿尔茨海默症的关键靶标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7cf93e9654)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1352685, encodeId=b91c1352685ee, content=<a href='/topic/show?id=827d9996311' target=_blank style='color:#2F92EE;'>#靶标#</a>, objectTitle=Nature:儿童攻击性眼肿瘤治疗的新靶标基因, objectType=article, longId=3755, objectId=d3d53e55a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d3d53e55a1, replyNumber=0, likeNumber=72, createdTime=2012-01-24, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d3d53e55a1, moduleTitle=Nature:儿童攻击性眼肿瘤治疗的新靶标基因, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d3d53e55a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1352684, encodeId=d77b13526840b, content=<a href='/topic/show?id=827d9996311' target=_blank style='color:#2F92EE;'>#靶标#</a>, objectTitle=IGF-1R可能成为三阴性乳腺癌的治疗靶标, objectType=article, longId=3662, objectId=e3673662a0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e3673662a0, replyNumber=0, likeNumber=63, createdTime=2012-01-08, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e3673662a0, moduleTitle=IGF-1R可能成为三阴性乳腺癌的治疗靶标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e3673662a0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1352683, encodeId=a63f13526836b, content=<a href='/topic/show?id=827d9996311' target=_blank style='color:#2F92EE;'>#靶标#</a>, objectTitle=Mol. Cell：启动癌细胞对糖嗜好的丙酮酸脱氢酶激酶或为抗癌靶标, objectType=article, longId=3651, objectId=83df3651da, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=83df3651da, replyNumber=0, likeNumber=88, createdTime=2012-01-08, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=83df3651da, moduleTitle=Mol. Cell：启动癌细胞对糖嗜好的丙酮酸脱氢酶激酶或为抗癌靶标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=83df3651da)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1352682, encodeId=10841352682b2, content=<a href='/topic/show?id=827d9996311' target=_blank style='color:#2F92EE;'>#靶标#</a>, objectTitle=JCI：鉴定出阻止乳腺癌扩散的新靶标, objectType=article, longId=3644, objectId=a2ba364403, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a2ba364403, replyNumber=0, likeNumber=70, createdTime=2012-01-08, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a2ba364403, moduleTitle=JCI：鉴定出阻止乳腺癌扩散的新靶标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a2ba364403)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1352681, encodeId=299613526817b, content=<a href='/topic/show?id=827d9996311' target=_blank style='color:#2F92EE;'>#靶标#</a>, objectTitle=nesfatin-1: 控制血糖潜在新靶标, objectType=article, longId=3024, objectId=1c933024b6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1c933024b6, replyNumber=0, likeNumber=86, createdTime=2011-08-24, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1c933024b6, moduleTitle=nesfatin-1: 控制血糖潜在新靶标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1c933024b6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1352680, encodeId=4ce11352680f9, content=<a href='/topic/show?id=827d9996311' target=_blank style='color:#2F92EE;'>#靶标#</a>, objectTitle=糖尿病治疗潜在新靶标：糖异生通路和PEPCK1, objectType=article, longId=2826, objectId=5e8a2826b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5e8a2826b8, replyNumber=0, likeNumber=84, createdTime=2011-07-14, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5e8a2826b8, moduleTitle=糖尿病治疗潜在新靶标：糖异生通路和PEPCK1, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5e8a2826b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1352679, encodeId=47cc13526e912, content=<a href='/topic/show?id=827d9996311' target=_blank style='color:#2F92EE;'>#靶标#</a>, objectTitle=Circulation: 2型糖尿病血压靶标不应＜130 mmHg, objectType=article, longId=2697, objectId=8c2d269e3d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8c2d269e3d, replyNumber=0, likeNumber=83, createdTime=2011-06-12, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8c2d269e3d, moduleTitle=Circulation: 2型糖尿病血压靶标不应＜130 mmHg, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8c2d269e3d)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

靶标

2020-05-29

zhaojie88 (审核中...)

前往app查看评论内容

#靶标#

Breast Cancer Res：蛋白Perp与细胞桥粒或成抑制乳腺癌新靶标

2012-04-27

zhaojie88 (审核中...)

前往app查看评论内容

#靶标#

ImmunoCellular公司获卵巢癌新靶标EphA2使用许可

2012-04-27

zhaojie88 (审核中...)

前往app查看评论内容

#靶标#

Nature：FLT3突变成急性髓细胞白血病治疗靶标

2012-04-19

zhaojie88 (审核中...)

前往app查看评论内容

#靶标#

EGFR可以作为NSCLC治疗靶标

2012-04-15

zhaojie88 (审核中...)

前往app查看评论内容

#靶标#

Cancer Cell：鉴定出混合性白血病的新药物靶标

2012-04-12

zhaojie88 (审核中...)

前往app查看评论内容

#靶标#

Nat.Med：HIPK2激酶——肾脏疾病药物新靶标

2012-04-12

zhaojie88 (审核中...)

前往app查看评论内容

#靶标#

Nat.Med：HIPK2激酶——肾脏疾病药物新靶标

2012-03-17

zhaojie88 (审核中...)

前往app查看评论内容

#靶标#

Cell：miR-124可能成为肝癌治疗新靶标

2012-03-12

zhaojie88 (审核中...)

前往app查看评论内容

#靶标#

脂肪酸合成酶或成糖尿病治疗新靶标

2012-02-26

zhaojie88 (审核中...)

前往app查看评论内容

#靶标#

Nat Med：去泛素酶USP15是潜在抗癌治疗靶标

2012-02-26

zhaojie88 (审核中...)

前往app查看评论内容

#靶标#

Ann Neurol:大脑中的12/15-lipoxygenase可能是控制阿尔茨海默症的关键靶标

2012-01-31

zhaojie88 (审核中...)

前往app查看评论内容

#靶标#

Nature:儿童攻击性眼肿瘤治疗的新靶标基因

2012-01-24

zhaojie88 (审核中...)

前往app查看评论内容

#靶标#

IGF-1R可能成为三阴性乳腺癌的治疗靶标

2012-01-08

zhaojie88 (审核中...)

前往app查看评论内容

#靶标#

Mol. Cell：启动癌细胞对糖嗜好的丙酮酸脱氢酶激酶或为抗癌靶标

2012-01-08

zhaojie88 (审核中...)

前往app查看评论内容

#靶标#

JCI：鉴定出阻止乳腺癌扩散的新靶标

2012-01-08

zhaojie88 (审核中...)

前往app查看评论内容

#靶标#

nesfatin-1: 控制血糖潜在新靶标

2011-08-24

zhaojie88 (审核中...)

前往app查看评论内容

#靶标#

糖尿病治疗潜在新靶标：糖异生通路和PEPCK1

2011-07-14

zhaojie88 (审核中...)

前往app查看评论内容

#靶标#

Circulation: 2型糖尿病血压靶标不应＜130 mmHg

2011-06-12

科室
- - 订阅+
  - 更多科室
工具
服务